Literature DB >> 12569966

A focused review on the use of botulinum toxins for neuropathic pain.

Charles E Argoff1.   

Abstract

Understanding the pathophysiology of a pain syndrome is helpful in selecting appropriate treatment strategies. Nociceptive pain is related to damage to tissues due to thermal, chemical, mechanical, or other types of irritants. Neuropathic pain results from injury to the peripheral or central nervous system. Common examples of neuropathic pain include postherpetic neuralgia, diabetic neuropathy, complex regional pain syndrome, and pain associated with spinal cord injuries. Nociceptive pain may have similar clinical characteristics to neuropathic pain. It is also possible for acute nociceptive pain to become neuropathic in nature, as with myofascial pain syndrome. A clear benefit of botulinum toxin therapy for treatment of neuropathic pain disorders is that it often relieves pain symptoms. Although the precise mechanism of pain relief is not completely understood, the injection of botulinum toxin may reduce various substances that sensitize nociceptors. As a result, botulinum toxin types A and B are now being actively studied in nociceptive and neuropathic pain disorders to better define their roles as analgesics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12569966     DOI: 10.1097/00002508-200211001-00010

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  27 in total

1.  Swimmer's headache, or supraorbital neuralgia.

Authors:  John C O'Brien
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

Review 2.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

3.  Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.

Authors:  Larissa Bittencourt da Silva; Ali Karshenas; Flemming Winther Bach; Sten Rasmussen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Pain Res Manag       Date:  2014 May-Jun       Impact factor: 3.037

Review 4.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

5.  Comparative evaluation of the potency and antigenicity of two distinct BoNT/A-derived formulations.

Authors:  M Brown; G Nicholson; M C Ardila; A Satorius; R S Broide; K Clarke; T Hunt; J Francis
Journal:  J Neural Transm (Vienna)       Date:  2012-07-29       Impact factor: 3.575

6.  Botulinum toxin a does not decrease calf pain or improve ROM during limb lengthening: a randomized trial.

Authors:  Dong Hoon Lee; Keun Jung Ryu; Dong Eun Shin; Hyun Woo Kim
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

7.  The Use of Botulinum Toxins for Chronic Pain and Headaches.

Authors:  Charles E. Argoff
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

8.  Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain.

Authors:  Jack Fu; An Ngo; Ki Shin; Eduardo Bruera
Journal:  J Palliat Med       Date:  2013-11-16       Impact factor: 2.947

Review 9.  Cranial neuralgias: from physiopathology to pharmacological treatment.

Authors:  Roberto De Simone; Angelo Ranieri; Leonilda Bilo; Chiara Fiorillo; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

10.  Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.

Authors:  Haley B Naik; Seth M Steinberg; Lindsay A Middelton; Stephen M Hewitt; Rena C Zuo; W Marston Linehan; Heidi H Kong; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.